[250 Pages Report] As per Future Market Insights’ latest industry analysis, the global robotic biopsy devices market was valued at around US$ 386.4 Mn in 2021 and is projected to exhibit a CAGR of 9.4% over the forecast period. The market is set to reach US$ 1.1 Bn in 2032.
One of the most significant cutting-edge technologies in neurosurgery is robot-assisted biopsy for brain tumors. Robot-assisted biopsy is used to increase the safety and effectiveness of biopsy technique, which is highly desired when organizing the management of tumor pathology.
| Attributes | Key Statistics |
| Global Robotic Biopsy Devices Market Estimated Size (2022) | US$ 435.6 Mn |
| Projected Market Valuation (2032) | US$ 1.1 Bn |
| Value-based CAGR 2022-2032 | 9.4% |
| Collective Value Share: Top 5 Countries | 50.5% |
Request Sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-15412
The main objective of this cutting-edge technology is to add safety equipment to the modern neurosurgery operative inventory so that it can methodically improve the precision and accuracy in operation theaters, which is not otherwise conceivable. Additionally, robotic biopsy makes the thorough preoperative process easier than other types.
The market for robotic biopsy devices is anticipated to grow at a fast pace over the projected years due to rising need for safe and effective minimally invasive procedures and growing use of automated systems in the healthcare sector. It can be further attributed to rapid transformation of conventional healthcare systems to integrated digital technology.
Key Takeaways: Robotic Biopsy Devices Market
- By product, the systems segment is expected to showcase high growth at a CAGR of 4% by the end of 2032.
- By application, the brain biopsy category is leading the global robotic biopsy devices market and is projected to exhibit a CAGR of 3% during the forecast period.
- By end user, hospitals held around 5% of the global robotic biopsy devices market share in 2021.
- The U.S. currently dominates the North America robotic biopsy devices market and it had generated a share of about 8% in 2021.
- The U.K. is set to hold a share of nearly 2% in the global robotic biopsy devices market during the assessment period.
“Increasing use of automated technologies for surgical procedures and growing global burden of chronic diseases are expected to drive sales of robotic biopsy devices,” says an analyst of Future Market Insights.
Ask An Analyst @ https://www.futuremarketinsights.com/ask-the-analyst/rep-gb-15412
Competition Landscape: Robotic Biopsy Devices Market
The market for robotic biopsy devices is oligopolistic, with the presence of a few established manufacturers. Product range of every player in the market varies as per the competitors’ licensed novel devices with unique applications. Key players are striving to gain regulatory authorizations for creating new medical devices, generating high product sales, and initiating marketing purposes.
- In October 2021, Medtronic reported that the Hugo robotic-assisted surgery (RAS) system had been granted the CE (Conformité Européenne) Mark, allowing for sales of the system across Europe.
What Does the Robotic Biopsy Devices Market Report Cover?
Future Market Insights offers a unique perspective and actionable insights on the robotic biopsy devices market in its latest study, presenting a historical demand assessment of 2012 – 2021 and projections for 2022 – 2032.
The research study is based on the product (systems and instrument & accessories), application (lung biopsy, brain biopsy, prostate biopsy, and others), and end user (hospitals, ambulatory surgical centers, and academic & research institutes) across seven key regions of the world.
Key Players :
- Medtronic
- Renishaw plc
- iSYS Medizintechnik GmbH
- Mazor Robotics
- Biobot Surgical Pte Ltd
- Medrobotics
- Medtech SA
Buy Now/Purchase @ https://www.futuremarketinsights.com/checkout/15412
Robotic Biopsy Devices Market Outlook by Category
By Product:
- Systems
- Instrument & Accessories
By Application:
- Brain Biopsy
- Lung Biopsy
- Prostate biopsy
- Others
By End User:
- Hospitals
- Ambulatory Surgical Centers
- Academic & Research Institutes
About FMI:
Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.
Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs